|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Desmedt C, Haibe-Kains B, Wirapati P,
Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M and
Sotiriou C: Biological processes associated with breast cancer
clinical outcome depend on the molecular subtypes. Clin Cancer Res.
14:5158–5165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tran B and Bedard PL: Luminal-B breast
cancer and novel therapeutic targets. Breast Cancer Res.
13:2212011. View
Article : Google Scholar
|
|
4
|
Hayes EL and Lewis-Wambi JS: Mechanisms of
endocrine resistance in breast cancer: An overview of the proposed
roles of noncoding RNA. Breast Cancer Res. 17:402015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sotiriou C, Neo SY, McShane LM, Korn EL,
Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL and Liu ET: Breast
cancer classification and prognosis based on gene expression
profiles from a population-based study. Proc Natl Acad Sci USA.
100:10393–10398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Assi HA, Khoury KE, Dbouk H, Khalil LE,
Mouhieddine TH and El Saghir NS: Epidemiology and prognosis of
breast cancer in young women. J Thorac Dis. 5(Suppl 1): S2–S8.
2013.PubMed/NCBI
|
|
7
|
Sun X, Jiao X, Pestell TG, Fan C, Qin S,
Mirabelli E, Ren H and Pestell RG: MicroRNAs and cancer stem cells:
The sword and the shield. Oncogene. 33:4967–4977. 2014. View Article : Google Scholar
|
|
8
|
Rothschild SI: microRNA therapies in
cancer. Mol Cell Ther. 2:72014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costa PM and Pedroso de Lima MC: MicroRNAs
as molecular targets for cancer therapy: On the modulation of
microRNA expression. Pharmaceuticals (Basel). 6:1195–1220. 2013.
View Article : Google Scholar
|
|
10
|
Sun X, Tang SC, Xu C, Wang C, Qin S, Du N,
Liu J, Zhang Y, Li X, Luo G, et al: Dicer regulated let-7
expression levels in p53-induced cancer repression requires cyclin
D1. J Cell Mol Med. 19:1357–1365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
12
|
Laezza C, d'Alessandro A, Malfitano AM and
Bifulco M: Anandamide inhibits the Wnt/β-catenin signalling pathway
in human breast cancer MDA MB 231 cells. Eur J Cancer.
49:2066–2067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malanchi I, Santamaria-Martinez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Cicalese A, Bonizzi G, Pasi CE, Faretta M,
Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP and Pelicci
PG: The tumor suppressor p53 regulates polarity of self-renewing
divisions in mammary stem cells. Cell. 138:1083–1095. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oliveras-Ferraros C, Cufi S,
Vazquez-Martin A, Torres-Garcia VZ, Del Barco S, Martin-Castillo B
and Menendez JA: Micro (mi) RNA expression profile of breast cancer
epithelial cells treated with the anti-diabetic drug metformin:
Induction of the tumor suppressor miRNA let-7a and suppression of
the TGFβ-induced oncomiR miRNA-181a. Cell Cycle. 10:1144–1151.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Wang C, Wang Z, Dampier W, Wu K,
Casimiro MC, Chepelev I, Popov VM, Quong A, Tozeren A, et al:
Attenuation of Forkhead signaling by the retinal determination
factor DACH1. Proc Natl Acad Sci USA. 107:6864–6869. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsang WP and Kwok TT: Let-7a microRNA
suppresses therapeutics-induced cancer cell death by targeting
caspase-3. Apoptosis. 13:1215–1222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saridaki Z, Weidhaas JB, Lenz HJ,
Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW,
Zhang W, Yang D, et al: A let-7 microRNA-binding site polymorphism
in KRAS predicts improved outcome in patients with metastatic
colorectal cancer treated with salvage cetuximab/panitumumab
monotherapy. Clin Cancer Res. 20:4499–4510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Worringer KA, Rand TA, Hayashi Y, Sami S,
Takahashi K, Tanabe K, Narita M, Srivastava D and Yamanaka S: The
let-7/LIN-41 pathway regulates reprogramming to human induced
pluripotent stem cells by controlling expression of
prodifferentiation genes. Cell Stem Cell. 14:40–52. 2014.
View Article : Google Scholar
|
|
23
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar
|
|
24
|
Ohno S, Takanashi M, Sudo K, Ueda S,
Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, et
al: Systemically injected exosomes targeted to EGFR deliver
antitumor microrna to breast cancer cells. Mol Ther. 21:185–191.
2013. View Article : Google Scholar :
|
|
25
|
Laezza C, D'Alessandro A, Paladino S,
Maria Malfitano A, Chiara Proto M, Gazzerro P, Pisanti S, Santoro
A, Ciaglia E and Bifulco M; Endocannabinoid Research Group:
Anandamide inhibits the Wnt/β-catenin signalling pathway in human
breast cancer MDA MB 231 cells. Eur J Cancer. 48:3112–3122. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taurin S, Sandbo N, Yau DM, Sethakorn N
and Dulin NO: Phosphorylation of beta-catenin by PKA promotes
ATP-induced proliferation of vascular smooth muscle cells. Am J
Physiol Cell Physiol. 294:C1169–C1174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Midwood KS and Orend G: The role of
tenascin-C in tissue injury and tumorigenesis. J Cell Commun
Signal. 3:287–310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi AR, Park JR, Kim RJ, Kim SR, Cho SD,
Jung JY and Nam JS: Inhibition of Wnt1 expression reduces the
enrichment of cancer stem cells in a mouse model of breast cancer.
Biochem Biophys Res Commun. 425:436–442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He B and Jablons DM: Wnt signaling in stem
cells and lung cancer. Cancer Stem Cells. Wiestler OD, Haendler B
and Mumberg D: Springer-Verlag; Berlin: pp. 27–58. 2007, View Article : Google Scholar
|
|
31
|
Sun X, Qin S, Fan C, Xu C, Du N and Ren H:
Let-7: A regulator of the ERalpha signaling pathway in human breast
tumors and breast cancer stem cells. Oncol Rep. 29:2079–2087.
2013.PubMed/NCBI
|
